Cristina Martín-Lorente
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 10
-
- PARP inhibition in cancer therapy 8
- Cancer Immunotherapy and Biomarkers 3
-
- BRCA gene mutations in cancer 3
-
- Immunotherapy and Immune Responses 2
- Toxin Mechanisms and Immunotoxins 2
-
- Endometrial and Cervical Cancer Treatments 2
-
- Cervical Cancer and HPV Research 2
- Co-authors
- María Virtudes CéspedesJosé Luís CorcheroRaúl RuizElisa LlurbaFrancisco RodríguezRamón RoviraMaría Rodríguez GámezJosep Balart
- Partner nations
- SpainCanadaUnited States
In The Last Decade
Cristina Martín-Lorente
14 papers receiving 276 citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Biomaterials 90
- Reproductive Medicine 58
- Oncology 89
- Pharmaceutical Science 14
- Biomedical Engineering 87
Countries citing papers authored by Cristina Martín-Lorente
This map shows the geographic impact of Cristina Martín-Lorente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Martín-Lorente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Martín-Lorente more than expected).
Fields of papers citing papers by Cristina Martín-Lorente
This network shows the impact of papers produced by Cristina Martín-Lorente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Martín-Lorente. The network helps show where Cristina Martín-Lorente may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cristina Martín-Lorente, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 1 | |
| 5 | Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challengesbreakdown → | 2022 | 169 |
| 6 | 2022 | 27 | |
| 7 | 2022 | 16 | |
| 8 | 2022 | 2 | |
| 9 | 2021 | 29 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2015 | 5 | |
| 13 | 2014 | 2 | |
| 14 | 2014 | 2 | |
| 15 | 2014 | 15 |
About Cristina Martín-Lorente
Cristina Martín-Lorente is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology, having authored 15 papers that have together received 279 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), PARP inhibition in cancer therapy (8 papers), BRCA gene mutations in cancer (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Cervical Cancer and HPV Research (2 papers) and Toxin Mechanisms and Immunotoxins (2 papers). The work is most often cited by research in Biomaterials (90 citations), Reproductive Medicine (58 citations) and Oncology (89 citations). Cristina Martín-Lorente has collaborated with scholars based in Spain, Canada and United States. Frequent co-authors include María Virtudes Céspedes, José Luís Corchero, Raúl Ruiz, Elisa Llurba, Francisco Rodríguez, Ramón Rovira, María Rodríguez Gámez, Josep Balart, José Alejandro Pérez Fidalgo and Maria-Pilar Barretina-Ginesta. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Biomolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.